PROGENProstatype Genomics AB (publ)
0.1985SEK+11.20%Mkt Cap: 2.95M $P/E:

Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, glea…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$201.86BUSDP/E 29.8
DHR
Danaher Corporation
$145.10BUSDP/E 39.7
LONN
Lonza Group AG
$45.85BUSDP/E 44.2
IDXX
IDEXX Laboratories, Inc.
$45.44BUSDP/E 42.4
NTRA
Natera, Inc.
$38.64BUSD
A
Agilent Technologies, Inc.
$38.44BUSDP/E 27.3
WAT
Waters Corporation
$37.13BUSDP/E 48.1
IQV
IQVIA Holdings Inc.
$35.13BUSDP/E 26.2
ILMN
Illumina, Inc.
$28.78BUSDP/E 34.6
MTD
Mettler-Toledo International Inc.
$26.98BUSDP/E 31.4
DGX
Quest Diagnostics Incorporated
$23.18BUSDP/E 23.1
LH
Labcorp Holdings Inc.
$23.12BUSDP/E 25.0
GH
Guardant Health, Inc.
$20.55BUSD
MEDP
Medpace Holdings, Inc.
$15.36BUSDP/E 33.9
ERF
Eurofins Scientific SE
$13.06BUSDP/E 27.3
RVTY
Revvity, Inc.
$12.46BUSDP/E 53.7
CRL
Charles River Laboratories International, Inc.
$11.04BUSD
BIM
bioMérieux S.A.
$9.26BUSDP/E 21.6
BLLN
BillionToOne, Inc.
$5.90BUSDP/E 237.4
TWST
Twist Bioscience Corporation
$5.68BUSD
SHC
Sotera Health Company
$5.21BUSDP/E 44.6
RDNT
RadNet, Inc.
$4.95BUSD
VCYT
Veracyte, Inc.
$4.73BUSDP/E 54.8
DIA
DiaSorin S.p.A.
$3.75BUSDP/E 26.5
ADPT
Adaptive Biotechnologies Corporation
$3.54BUSD
GRAL
GRAIL, Inc.
$3.09BUSD
CDNA
CareDx, Inc.
$2.08BUSD
NEO
NeoGenomics, Inc.
$1.93BUSD
WGS
GeneDx Holdings Corp.
$1.83BUSD
VIMIAN
Vimian Group AB (publ)
$1.64BUSDP/E 41.7
PSNL
Personalis, Inc.
$1.63BUSD
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CBAV
Clínica Baviera, S.A.
$1.02BUSDP/E 21.4
OPK
OPKO Health, Inc.
$898.56MUSD
CSTL
Castle Biosciences, Inc.
$734.89MUSD
LBIRD
Lumibird SA
$616.40MUSDP/E 40.2
MYGN
Myriad Genetics, Inc.
$584.63MUSD
FLGT
Fulgent Genetics, Inc.
$583.63MUSD
VOX
Voxel S.A.
$293.12MUSDP/E 2.9
EDT
Spectral Medical Inc.
$292.75MUSD
BDSX
Biodesix, Inc.
$206.70MUSD
IMDX
Insight Molecular Diagnostics Inc.
$152.09MUSD
SLV
Selvita S.A.
$139.43MUSD
SCP
Scope Fluidics S.A.
$97.25MUSD
XGN
Exagen Inc.
$102.68MUSD
ALECR
Eurofins-Cerep SA
$89.37MUSDP/E 17.2
BIOPOR
BioPorto A/S
$73.19MUSD
PANG
Pangaea Oncology, S.A.
$58.55MUSD
PRPO
Precipio, Inc.
$42.32MUSD
NN6
NanoRepro AG
$30.71MUSD
ABDX
Abingdon Health Plc
$26.61MUSD
GDR
genedrive plc
$20.94MUSD
SENZA
SenzaGen AB
$16.60MUSD
IMMNOV
Immunovia AB (publ)
$12.04MUSD
BMX
BioMaxima S.A.
$9.95MUSD
VRCI
Verici Dx plc
$8.70MUSD
XWEL
XWELL, Inc.
$8.87MUSD
ALPRE
Predilife S.A.
$7.73MUSD
PRM
Proteome Sciences plc
$7.43MUSD
NDRA
ENDRA Life Sciences Inc.
$6.69MUSD
OBD
Oxford BioDynamics Plc
$6.06MUSD
AVCR
Avricore Health Inc.
$5.06MUSD
BIAF
bioAffinity Technologies, Inc.
$4.47MUSD
JUMP
Leveljump Healthcare Corp.
$4.44MUSD
TELO
Telo Genomics Corp.
$3.29MUSD
ISPC
iSpecimen Inc.
$3.18MUSD
PRPH
ProPhase Labs, Inc.
$869.0KUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$19.6KUSD
Indicators:|

Key Statistics

Company
Market Cap2.95M $
Enterprise Value763.41K $
Revenue (TTM)56.82K $
Gross Profit56.82K $
Net Income (TTM)-4.26M $
Revenue/Share0.0017 USD
Last Price0.1985 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.99
PEG
EV/EBITDA-0.22
EV/Revenue13.44
P/S51.99
P/B0.44
EPS (TTM)-0.50
EPS (Forward)-0.10
52W Range
0.14053% of range2.280
52W High2.280 SEK
52W Low0.1405 SEK
Profitability
Gross Margin100.00%
Oper. Margin-5423.28%
EBITDA Margin0.00%
Profit Margin-7492.09%
ROE-167.75%
ROA-87.50%
Growth
Revenue Growth-25.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-2.28M $
CapEx (TTM)1.29M $
FCF Margin-4236.81%
FCF Yield-81.50%
Net Debt-360.42K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.20
Current Ratio0.44
Quick Ratio0.40
Book Value/Sh0.4480 SEK
Cash/Share0.1530 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:1000
Split DateOct 31, 2024
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.155.57M
Float40.52M
Insiders28.84%
Institutions0.00%
Technical
SMA 500.4425 (-55.1%)
SMA 2000.7509 (-73.6%)
Beta1.49
S&P 52W Chg19.63%
Avg Vol (30d)959.39K
Avg Vol (10d)2.26M
Technical Indicators
RSI (14)36.5
MACD-0.0907
MACD Signal-0.0788
MACD Hist.-0.0119
BB Upper0.6360 SEK
BB Middle0.3501 SEK
BB Lower0.0642 SEK
BB Width163.31%
ATR (14)0.1316 SEK
Vol Ratio (20d)0.71x